Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
2,588,285
|
2,426,597
|
2,405,186
|
2,282,449
| Cost of Revenue | 675,818 | 597,269 | 617,345 | 580,931 | |
Gross Profit
|
1,912,467
|
1,829,328
|
1,787,841
|
1,701,518
| |
|
Operating Expenses |
|
Research Development | 439,659 | 465,831 | 396,244 | 458,211 |
|
Selling General and Administrative | 365,825 | 319,583 | 332,505 | 443,121 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,106,983
|
1,043,914
|
1,059,092
|
800,186
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,386 | (3,505) | (1,075) | (34,085) |
|
Earnings Before Interest And Taxes | 1,108,369 | 1,040,409 | 1,058,017 | 766,101 |
|
Interest Expense | 85,906 | 89,322 | 88,418 | 97,270 |
|
Income Before Tax | 1,022,463 | 951,087 | 969,599 | 668,831 |
|
Income Tax Expense | 263,504 | 280,052 | 263,525 | 231,300 |
|
Minority Interest | 3,582 | 4,470 | 5,490 | 4,425 |
|
|
|
Net Income From Continuing Ops | 762,541 | 675,505 | 711,564 | 441,956 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
762,541
|
675,505
|
711,564
|
441,956
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
762,541
|
675,505
|
711,564
|
441,956
|
|